The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis
Abstract
We attempted to investigate whether vitamin K2 (menatetrenone) treatment effectively prevents the incidence of new fractures in osteoporosis. A total of 241 osteoporotic patients were enrolled in a 24-month randomized open label study. The control group (without treatment; n = 121) and the vitamin K2–treated group (n = 120), which received 45 mg/day orally vitamin K2, were followed for lumbar bone mineral density (LBMD; measured by dual-energy X-ray absorptiometry [DXA]) and occurrence of new clinical fractures. Serum level of Glu-osteocalcin (Glu-OC) and menaquinone-4 levels were measured at the end of the follow-up period. Serum level of OC and urinary excretion of deoxypyridinoline (DPD) were measured before and after the treatment. The background data of these two groups were identical. The incidence of clinical fractures during the 2 years of treatment in the control was higher than the vitamin K2–treated group (χ2 = 10.935; p = 0.0273). The percentages of change from the initial value of LBMD at 6, 12, and 24 months after the initiation of the study were −1.8 ± 0.6%, −2.4 ± 0.7%, and −3.3 ± 0.8% for the control group, and 1.4 ± 0.7%, −0.1 ± 0.6%, and −0.5 ± 1.0% for the vitamin K2–treated group, respectively. The changes in LBMD at each time point were significantly different between the control and the treated group (p = 0.0010 for 6 months, p = 0.0153 for 12 months, and p = 0.0339 for 24 months). The serum levels of Glu-OC at the end of the observation period in the control and the treated group were 3.0 ± 0.3 ng/ml and 1.6 ± 0.1 ng/ml, respectively (p < 0.0001), while the serum level of OC measured by the conventional radioimmunoassay (RIA) showed a significant rise (42.4 ± 6.9% from the basal value) in the treated group at 24 months (18.2 ± 6.1% for the controls; p = 0.0081). There was no significant change in urinary DPD excretion in the treated group. These findings suggest that vitamin K2 treatment effectively prevents the occurrence of new fractures, although the vitamin K2–treated group failed to increase in LBMD. Furthermore, vitamin K2 treatment enhances γ-carboxylation of the OC molecule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women
Ross, P. D., Davis, J. W., Epstein, R. S., & Wasnich, R. D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-11-919 · Cited by 1,107
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures
ETTINGER, B., GENANT, H. K., & CANN, C. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-3-319 · Cited by 774
Hauschka, P. V., Lian, J. B., & Gallop, P. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.10.3925 · Cited by 747
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc, P., Chapuy, M. C., Meunier, P. J., & Delmas, P. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116387 · Cited by 484
Uebelhart, D., Gineyts, E., Chapuy, M.-C., & Delmas, P. D. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90143-n · Cited by 424
Vergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3805 · Cited by 389
UEBELHART, D., SCHLEMMER, A., JOHANSEN, J. S., GINEYTS, E., CHRISTIANSEN, C., & DELMAS, P. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-367 · Cited by 361
Calcium-dependent .alpha.-helical structure in osteocalcin
Hauschka, P. V., & Carr, S. A. (1982) · Biochemistry · doi:10.1021/bi00539a038 · Cited by 327
Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone.
Price, P. A., Poser, J. W., & Raman, N. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3374 · Cited by 234
Orimo, H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T., & Ogawa, N. (1994) · Calcified Tissue International · doi:10.1007/bf00305521 · Cited by 222
Self-citationDiagnostic criteria of primary osteoporosis
Orimo, H., Sugioka, Y., Fukunaga, M., Muto, Y., Hotokebuchi, T., Gorai, I., Nakamura, T., Kushida, K., Tanaka, H., Ikai, T., et al. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050038 · Cited by 209
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Vergnaud, P. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.719 · Cited by 202
Association of Bone Mineral Density with Apolipoprotein E Phenotype
Shiraki, M., Shiraki, Y., Aoki, C., Hosoi, T., Inoue, S., Kaneki, M., & Ouchi, Y. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1438 · Cited by 196
Self-citationELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN K1IN OSTEOPOROSIS
HART, J. P., SHEARER, M. J., KLENERMAN, L., CATTERALL, A., REEVE, J., SAMBROOK, P. N., DODOS, R. A., BITENSKY, L., & CHAYEN, J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1268 · Cited by 165
Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women
Plantalech, L., Guillaumont, M., Vergnaud, P., Leclercq, M., & Dr. Delmas, P. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061111 · Cited by 160
Hodges, S. J., Pilkington, M. J., Stamp, T. C. B., Catterall, A., Shearer, M. J., Bitensky, L., & Chayen, J. (1991) · Bone · doi:10.1016/8756-3282(91)90027-g · Cited by 143
Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro
Hara, K., Akiyama, Y., Tajima, T., & Shiraki, M. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080504 · Cited by 108
Self-citationVitamin K2 promotes 1?,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts
Koshihara, Y., Hoshi, K., Ishibashi, H., & Shiraki, M. (1996) · Calcified Tissue International · doi:10.1007/bf00369212 · Cited by 105
Self-citationOrimo, H., Shiraki, M., TOMITA, A., Morii, H., Fujita, T., & Ohata, M. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050034 · Cited by 94
Self-citationSato, K., Okumura, F., Goshima, Y., Miyamae, T., & Misu, Y. (1993) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.62.145 · Cited by 91
Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures
Akiyama, Y., Hara, K., Tajima, T., Murota, S., & Morita, I. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90539-8 · Cited by 87
Effects of menatetrenone on prednisolone-induced bone loss in rats
Hara, K., Akiyama, Y., Ohkawa, I., & Tajima, T. (1993) · Bone · doi:10.1016/8756-3282(93)90309-x · Cited by 81
Shiraki, M., KUSHIDA, K., Yamazaki, K., Nagai, T., Inoue, T., & Orimo, H. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.211 · Cited by 79
Self-citationSix osteocalcin assays compared
Diego, E. M. D., Guerrero, R., & de la Piedra, C. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.11.2071 · Cited by 71
Shiraki, M., KUSHIDA, K., Fukunaga, M., Kishimoto, H., Kaneda, K., MINAGUCHI, H., Inoue, T., TOMITA, A., Nagata, Y., Nakashima, M., et al. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.191 · Cited by 51
Self-citationEffects of Menatetrenone on Bone Loss Induced by Ovariectomy in Rats
Akiyama, Y., Hara, K., Ohkawa, I., & Tajima, T. (1993) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.61.311 · Cited by 26
Biochemical short-term changes produced by hormonal replacement therapy
Aloia, J. F., Vaswani, A. N., Yeh, J. K., et al. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03347118 · Cited by 13
Cited by
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
Siris, E. S., Chen, Y.-T., Abbott, T. A., Barrett-Connor, E., Miller, P. D., Wehren, L. E., & Berger, M. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1108 · Cited by 1,093
Treatment of postmenopausal osteoporosis
Delmas, P. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08827-x · Cited by 681
The Role of Nutrients in Bone Health, from A to Z
Palacios, C. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500466174 · Cited by 425
Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR
Tabb, M. M., Sun, A., Zhou, C., Grün, F., Errandi, J., Romero, K., Pham, H., Inoue, S., Mallick, S., Lin, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303136200 · Cited by 387
Metadata
- Authors
- Shiraki, M., Shiraki, Y., Aoki, C., & Miura, M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03-01
- Volume
- 15
- Issue
- 3
- Pages
- 515-521
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1990123370
- Cited by
- 408
- References
- 32
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.